An FDA advisory committee meeting to review the vaccine’s application is scheduled for Feb. 26, and approval could soon follow.
The vaccine is administered in only one dose, so 20 million doses could fully vaccinate 20 million people.
Johnson & Johnson also said it is still on track to produce 100 million doses by June 30, according to The Hill.
More articles on pharmacy:
Pfizer vaccine prevents 98.9% of COVID-19 deaths, hospitalizations, Israel data shows
Most vaccine trials don’t report participants’ ethnicities
Most, least expensive US cities for prescription drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
